MICHELLE DEES: Open Payments
NPI 1871648642 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$599 in 32 payments from 10 companies in 2025. Trend: 2023 $51,012 · 2024 $37,340 · 2025 $599
Food & beverage: $599
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $219 |
| Axsome Therapeutics, Inc. | 7 | $139 |
| Tris Pharma Inc | 3 | $62 |
| Janssen Pharmaceuticals, Inc | 2 | $55 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Lilly USA, LLC | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: VRAYLAR, Auvelity, Dyanavel XR, SPRAVATO, COBENFY, REXULTI, CAPLYTA, ZEPBOUND.
Industry payments across IL — which companies pay providers there.
